Leung H, Mok V
Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
Hong Kong Med J. 2005 Dec;11(6):476-89.
To review the aetiology, diagnosis, and management of Parkinson's disease, with a local perspective.
Medline from 1966 onwards, and all major neurological journals and movement disorder journals were searched for evidence on the aetiology, diagnosis, and management of Parkinson's disease.
Key words for the literature search were "Parkinson's disease" and "Chinese" or "Hong Kong".
All relevant articles in English were reviewed.
The number of promising genes for familial Parkinson's disease is still expanding rapidly and there has been a wealth of studies on susceptibility genes for Parkinson's disease. Potential treatment choices include the use of agents thought to be neuroprotective, symptomatic treatment with drugs or surgery, and non-pharmacological treatments. Pharmacological treatment using a dopa-sparing strategy and continuous dopaminergic stimulation is now gaining support to address the issue of long-term motor complications. Surgical treatment with deep brain stimulation is safe and effective for refractory cases and has been increasingly utilised locally.
Medical therapy remains the mainstay of treatment and newer agents and treatment approaches are emerging, which will hopefully address the issue of neuroprotection and provide symptomatic treatment with fewer motor complications.
从本地视角回顾帕金森病的病因、诊断及治疗。
检索了1966年起的Medline以及所有主要的神经学杂志和运动障碍杂志,以获取有关帕金森病病因、诊断及治疗的证据。
文献检索的关键词为“帕金森病”以及“中国”或“香港”。
对所有相关英文文章进行了综述。
家族性帕金森病的潜在致病基因数量仍在迅速增加,并且已有大量关于帕金森病易感基因的研究。潜在的治疗选择包括使用被认为具有神经保护作用的药物、药物或手术的对症治疗以及非药物治疗。采用减少左旋多巴用量策略和持续多巴胺能刺激的药物治疗目前正获得支持,以解决长期运动并发症问题。深部脑刺激手术治疗对难治性病例安全有效,且在本地的应用越来越多。
药物治疗仍然是主要的治疗方法,新的药物和治疗方法不断涌现,有望解决神经保护问题并提供运动并发症较少的对症治疗。